Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/12/2003EP1282816A2 Improved assay techniques using nematode worms
02/12/2003EP1282815A2 Assay for cell cycle modulators
02/12/2003EP1282814A2 Breath test apparatus and methods
02/12/2003EP1282813A2 Use of colored metal binding proteins
02/12/2003EP1282734A2 Differentiable spectral bar code methods and systems
02/12/2003EP1282730A2 Compositions and methods for nucleic acid or polypeptide analyses
02/12/2003EP1282728A2 Methods for clinical diagnosis
02/12/2003EP1282724A2 Stain solution which is devoid of phenol
02/12/2003EP1282723A1 Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
02/12/2003EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
02/12/2003EP1282706A2 Natrium-calcium exchanger protein
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282695A1 Blood-compatible polymer surfaces
02/12/2003EP1282692A2 Sentinel virus ii
02/12/2003EP1282690A1 Isolation of precursor cells and their use for tissue repair
02/12/2003EP1282689A1 Specific inhibitors of ribosome recycling factor (rrf)
02/12/2003EP1282688A1 Ammonia-oxidizing bacteria
02/12/2003EP1282646A2 Human monoclonal antibodies to dendritic cells
02/12/2003EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same
02/12/2003EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
02/12/2003EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
02/12/2003EP1282425A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof
02/12/2003EP1282417A1 Creatinine biosensor
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003EP1150942A4 Improved compounds for protein binding
02/12/2003EP1135169B1 Use of a pharmaceutical composition comprising an anti-cancer agent and at least a peptide
02/12/2003EP1115400A4 Benzothiazole dioxetanes
02/12/2003EP1101096B1 Method of determining variable concentrations of ice in binary ice volumes
02/12/2003EP1082460A4 A novel method of diagnosing, monitoring, and staging prostate cancer
02/12/2003EP1080065A4 A method of permanent fluorescent assay
02/12/2003EP1035918B1 Device for measuring physiological parameters
02/12/2003EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use
02/12/2003EP0815261B1 Dna diagnostics based on mass spectrometry
02/12/2003EP0740783B1 Improvements in or relating to a consistency transmitter
02/12/2003EP0722569B1 A method and apparatus for detecting hemolysis in a fluid sample
02/12/2003EP0717749B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
02/12/2003EP0637246B1 Use of modified c-reactive protein for the preparation of a medicament for the treatment of cancer
02/12/2003CN2535805Y Tumor testing instrument
02/12/2003CN1397021A Immunochromatographic assay devices with separators
02/12/2003CN1397020A Method for detecting substance
02/12/2003CN1397019A Screening method
02/12/2003CN1397018A Method for determining alloy phase in plating layer and method for evaluating sliding property of alloy galvanized steel plate
02/12/2003CN1397017A Biosensor, measuring instrument for biosensor, and method of quantifying substrate
02/12/2003CN1397016A 一氧化碳检测器 Carbon monoxide detector
02/12/2003CN1397008A Method for isolating portion of layer of biological material
02/12/2003CN1396957A Method and kits for identifying elite event GAT-ZM1 in biological samples
02/12/2003CN1396954A Support for fixing nucleotide and process for producing the same
02/12/2003CN1396454A Process for preparing cross-linking antibody by solid-phase immunoadsorption method
02/12/2003CN1396453A Reagent kit for early diagnosis of acute myocardial infarction
02/12/2003CN1396452A Observation device for soil characteristic and observation method for soil characteristic
02/12/2003CN1396444A Improved investigating device and its using method
02/12/2003CN1101547C Automatic sample analysis instrument and its using method
02/12/2003CN1101546C Kit for detecting helicobacter pylori
02/11/2003WO2002014871A1 Method of detecting or assaying hbv
02/11/2003US6519583 Graphical viewer for biomolecular sequence data
02/11/2003US6519536 Method for determining the behaviour of a viscoelastic material
02/11/2003US6519534 Paper web breakage prediction using bootstrap aggregation of classification and regression trees
02/11/2003US6519355 Optical projection imaging system and method for automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease
02/11/2003US6519032 Fiber optic apparatus and use thereof in combinatorial material science
02/11/2003US6519025 Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
02/11/2003US6518747 Method and apparatus for quantitative determination of accumulations of magnetic particles
02/11/2003US6518567 Method for detecting elements in solutions and device for realizing the same
02/11/2003US6518403 Antibodies that bind an adipocyte-specific protein homolog
02/11/2003US6518278 Administering a synergistically effective amount of irinotecane and subsequently with a synergistically effective amount of cis-oxalato (1R,2R-diaminocyclohexane) Pt (II)
02/11/2003US6518069 Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders
02/11/2003US6518068 Luminescence detection workstation
02/11/2003US6518060 Apparatus for use in chemical and microbiological analysis
02/11/2003US6518058 Method of preparing polypeptides in cell-free system and device for its realization
02/11/2003US6518056 Apparatus, systems and method for assaying biological materials using an annular format
02/11/2003US6518055 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
02/11/2003US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of
02/11/2003US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells
02/11/2003US6518038 Detection and quantification of one or more target analytes in a sample using spatially localized analyte reproduction
02/11/2003US6518037 Two-component system that controls bacterial membrane synthesis
02/11/2003US6518036 Method of permanent fluorescent assay
02/11/2003US6518035 methods of screening for a molecule that inhibits the expression or activity of a protein encoded by a target gene which affects the fitness of a cell. The methods are based on a co-culture assay, and entail culturing together two cell
02/11/2003US6518032 Rapid methods for identifying modifiers of cellular apoptosis activity
02/11/2003US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction
02/11/2003US6518028 Methods for the early diagnosis of ovarian and prostate cancer
02/11/2003US6518027 Sample preparation method and a sample preparation apparatus for DNA analysis
02/11/2003US6518024 Apparatus for accurately detecting insertion of nucleotide into nucleotide sequence chains; for use in detection polymorphisms
02/11/2003US6518021 Method for extracting quantitative information relating to an influence on a cellular response
02/11/2003US6518018 RNA-antibody fusions and their selection
02/11/2003US6518016 Screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding
02/11/2003US6518015 Peptide comprising the sequence CAFRQVC and methods using it
02/11/2003US6518012 Method for increasing the expression of CD40 gene in tumor cells in vitro comprising the step of contacting the tumor cells with an effective amount of a deacetylase inhibitor wherein said amount of deacetylase inhibitor increases the
02/11/2003US6518011 Monitoring the processing of epitope-tagged beta-APP. More specifically, the present invention relates to the use of such methods and composition for monitoring responses of cells expressing such epitope-tagged beta-APP or segments of cell
02/11/2003US6517872 Cell cultures that express fibroblast growth factor receptor 3; bone and/or cartilage repair; identification and locali-zation of tumors; binding targeting cytotoxic agents
02/11/2003US6517856 Insecticide resistance assay
02/11/2003US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2
02/11/2003US6517844 Inactivated bordetella avium or ornithobacterium rhino-tracheale bacterin and a preservative; oral administration with water
02/11/2003US6517837 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer
02/11/2003US6517811 Compounds for cancer imaging and therapy
02/11/2003US6517783 Receptacles for containing one or more substances; transfer device capable of taking contact-limiting elements from holding structure into contact with receptacle substances
02/11/2003US6517782 Reaction receptacle apparatus
02/11/2003US6517778 Solid phase
02/11/2003US6517702 To determine the oxidizable portion of exhaust gases in the presence of the reducible portion with the legally required precision
02/11/2003US6517696 Capillary electrophoretic apparatus, sample plate and sample injection method
02/11/2003US6517679 Quality control in papermaking, by measuring and analyzing the tension of paper webs